Serum 25-hydroxyvitamin D concentration, established and emerging cardiovascular risk factors and risk of myocardial infarction before the age of 60 years

Atherosclerosis

Volumn 223, Issue 1, 2012, Pages 223-229

  Deleskog, Anna ^a   Piksasova, Olga ^a   Silveira, Angela ^a   Samnegård, Ann ^b   Tornvall, Per ^a   Eriksson, Per ^a   Gustafsson, Sven ^a   Östenson, Claes Göran ^a   Öhrvik, John ^a   Hamsten, Anders ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Calcidiol; Calcitriol; Coronary artery disease; Risk factors; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROINSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHEMICAL ANALYSIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SEASONAL VARIATION; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; UNIVARIATE ANALYSIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE;

AGE OF ONSET; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SWEDEN; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84863101444     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.04.014     Document Type: Article

References (43)

1. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
2. Nagpal S., Na S.Q., Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005, 26:662-687.
3. Grandi N.C., Breitling L.P., Brenner H. Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med 2010, 51:228-233.
4. Giovannucci E., Liu Y., Rimm E.B., Hollis B.W., Fuchs C.S., Stampfer M.J., et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006, 98:451-459.
5. Baz-Hecht M., Goldfine A.B. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes 2010, 17:113-119.
6. Ascherio A., Munger K.L., Simon K.C. Vitamin D and multiple sclerosis. Lancet Neurol 2010, 9:599-612.
7. Watson K.E., Abrolat M.L., Malone L.L., Hoeg J.M., Doherty T., Detrano R., et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997, 96:1755-1760.
8. Doherty T.M., Tang W., Dascalos S., Watson K.E., Demer L.L., Shavelle R.M., et al. Ethnic origin and serum levels of 1 alpha,25-dihydroxyvitamin D-3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation 1997, 96:1477-1481.
9. Shen H., Bielak L.F., Ferguson J.F., Streeten E.A., Yerges-Armstrong L.M., Liu J., et al. Association of the vitamin D metabolism gene cyp24a1 with coronary artery calcification. Arteriosclerosis Thromb Vasc Biol 2010, 30:2648-2654.
10. Judd S.E., Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci 2009, 338:40-44.
11. Shea M.K., Benjamin E.J., Dupuis J., Massaro J.M., Jacques P.F., D'Agostino R.B., et al. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr 2009, 63:458-464.
12. Hunter D., De Lange M., Snieder H., Mac Gregor A.J., Swaminathan R., Thakker R.V., et al. Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res 2001, 16:371-378.
13. Pearce S.H.S., Cheetham T.D. Diagnosis and management of vitamin D deficiency. Br Med J. 2010, 340:11.
14. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004, 80:1689S-1696S.
15. Holick M.F., Chen T.C., Lu Z., Sauter E. Vitamin D and skin physiology: a d-lightful story. J Bone Miner Res 2007, 22:V28-V33.
16. Martins D., Wolf M., Pan D., Zadshir A., Tareen N., Thadani R., et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the united states - data from the third national health and nutrition examination survey. Arch Intern Med 2007, 167:1159-1165.
17. Wang T.J., Pencina S.L., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
18. Giovannucci E., Liu Y., Hollis B.W., Rimm E.B. 25-hydroxyvitamin D and risk of myocardial infarction in men - a prospective study. Arch Intern Med 2008, 168:1174-1180.
19. Pilz S., Tomaschitz A., März W., Drechsler C., Ritz E., Zittermann A., et al. Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf) 2011, 75:575-584.
20. Trivedi D.P., Doll R., Khaw K.T. Effect of four monthly oral vitamin D-3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. Br Med J 2003, 326:469-472.
21. Wang L., Manson J.E., Song Y., Sesso H.D. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010, 152:315-U388.
22. Hsia J., Heiss G., Ren H., Allison M., Dolan N.C., Greenland P., et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007, 115:846-854.
23. Bolland M.J., Grey A., Avenell A., Gamble G.D., Reid I.R. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the women's health initiative limited access dataset and meta-analysis. Br Med J 2011, 342.
24. Samnegård A., Silveira A., Lundman P., Boquist S., Odeberg J., Hulthe J., et al. Serum matrix metalloproteinase-3 concentration is influenced by mmp-3-1612 5a/6a promoter genotype and associated with myocardial infarction. J Intern Med 2005, 258:411-419.
25. Strandberg L.E., Ericsson C.G., O'Konor M.L., Bergstrand L., Lundin P., Rehnqvist N., et al. Diabetes mellitus is a strong negative prognostic factor in patients with myocardial infarction treated with thrombolytic therapy. J Intern Med 2000, 248:119-125.
26. Eriksson P., Deguchi H., Samnegård A., Lundman P., Boquist S., Tornvall P., et al. Human evidence that the cystatin c gene is implicated in focal progression of coronary artery disease. Arteriosclerosis Thromb Vasc Biol 2004, 24:551-557.
27. Tibshirani R., Friedman J.H. The elements of statistical learning: data mining, inference, and prediction. Springer series in statistics 2009, 228-235. Springer, New York, NY.
28. Altman D.G., Bland J.M. Measurement in medicine - the analysis of method comparison studies. Statistician 1983, 32:307-317.
29. Scragg R., Jackson R., Holdaway I., Woolard G., Woollard D. Changes in plasma vitamin levels in the 1st 48 hours after onset of acute myocardial-infarction. Am J Cardiol 1989, 64:971-974.
30. Pilz S., März W., Wellnitz B., Seelhorst U., Fahrleitner-Pammer A., Dimai H.P., et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008, 93:3927-3935.
31. Riachy R., Vandewalle B., Moerman E., Belaich S., Lukowiak B., Gmyr V., et al. 1,25-dihydroxyvitamin D-3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the fas receptor. Apoptosis 2006, 11:151-159.
32. Chiu K.C., Chu A., Go V.L.W., Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004, 79:820-825.
33. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 2006, 92:39-48.
34. Li Y.C. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 2003, 88:327-331.
35. Timms P.M., Mannan N., Hitman G.A., Noonan K., Mills P.G., Syndercombe-Court D., et al. Circulating mmp9, vitamin D and variation in the timp-1 response with vdr genotype: mechanisms for inflammatory damage in chronic disorders?. Qjm-an Int J Med 2002, 95:787-796.
36. Hamsten A., De Faire U., Walldius G., Dahlen G., Szamosi A., Landou C., et al. Plasminogen-activator inhibitor in plasma - risk factor for recurrent myocardial-infarction. Lancet 1987, 2:3-8.
37. Kohler H.P., Grant P.J. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000, 342:1792-1801.
38. Jorde R., Sneve M., Torjesen P., Figenschau Y., Hansen J.B., et al. Parameters of the thrombogram are associated with serum 25-hydroxyvitamin D levels at baseline, but not affected during supplementation with vitamin D. Thromb Res 2010, 125:e210-213.
39. Wu-Wong J.R., Nakane M., Ma J. Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cells. J Vasc Res 2007, 44:11-18.
40. Roder M.E., Porte D., Schwartz R.S., Kahn S.E. Disproportionately elevated proinsulin levels reflect the degree of impaired b cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998, 83:604-608.
41. Lindahl B., Dinesen B., Eliasson M., Roder M., Jansson J.H., Huhtasaari F., et al. High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population. Metabolism 1999, 48:1197-1202.
42. Zethelius B., Byberg L., Hales N., Lithell H., Berne C. Proinsulin is an independent predictor of coronary heart disease: report from a 27-year follow-up study. Circulation 2002, 105:2153-2158.
43. Grimnes G., Figenschau Y., Almås B., Jorde R. Vitamin D, insulin secretion, sensitivity, and lipids results from a case-control study and a randomized controlled trial using hyperglycemic clamp technique. Diabetes 2011, 60:2748-2757.